Back to Top
RESOURCES
Immuno-Oncology Articles
- Aducanumab: A Comprehensive Overview
- Belantamab: A Comprehensive Overview
- Tabalumab: A Comprehensive Overview
- Alsevalimab: A Comprehensive Overview
- Tilvestamab: A Comprehensive Overview
- Basiliximab: A Comprehensive Overview
- Promising Antibodies in Clinical Trials: 2024
- Promising Bispecifics in Clinical Trials: Aug 2023
- Therapeutic Antibody Sequences
- Antibodies in Preclinical & Clinical Studies
- The GAALIE Mutation in the Antibody Fc: Implications for Cancer Immunotherapy Engineering
- The Benefits of Bispecific Antibodies in Oncology Drug Development
- Enhancing Antibody-Dependent Cell-Mediated Cytotoxicity: A Comprehensive Analysis of Key Mutations
- FcRn: The Multifaceted Transporter Revolutionizing Drug Delivery
- Comprehensive Overview of Antibody Engineering Mutations
- Comprehensive Guide to Bispecific Antibodies in Immunotherapy
- Therapeutic Applications of Immunoglobulin Isotypes: Current Understanding and Future Directions
- A Researcher’s Guide to Trastuzumab Botidotin: Structure, Mechanism of Action, and Clinical Efficacy
- A Researcher’s Guide to Sibeprenlimab: Structure, Mechanism of Action, and Clinical Efficacy in IgAN
- A Researcher’s Guide to Picankibart: Structure, Mechanism of Action, and Clinical Efficacy in Psoriasis
- A Researcher’s Guide to Depemokimab: Structure, Mechanism of Action, and Clinical Efficacy in Eosinophilic Diseases
- A Researcher’s Guide to Narsoplimab: Structure, Mechanism of Action, and Clinical Efficacy in TA-TMA
- Bentracimab: The First-in-Class Reversal Agent for Ticagrelor
- Apitegromab: A Myostatin Inhibitor for Spinal Muscular Atrophy
Background Articles
- Making Your PhD a Success: A Guide for Doctoral Candidates
- Defending Your Doctoral Thesis: Navigating the PhD Viva
- Navigating the Publication Process: Tips for Life Science PhD Students
- Building Professional Relationships During Your PhD
- Maximizing Your Mentor-Mentee Relationship for PhD Success
- 10 Essential Time Management Strategies for PhD Students
- Lab Planning Documents
- A Beginner’s Guide: How to Write a Great Life Science Paper
- Isotype Controls: An Important Experimental Tool
- Common Modifications to Immunoglobulin Fc Sites to Silence Immune Effector Functions
- Life Science Salaries: What to Expect in the USA, UK, France and Germany
- Unlocking Combinatorial Immuno-Oncology: Why Clone B20-4.1.1 is Essential for Preclinical TME Research
- The Role of Anti-Mouse CD20 Clone 18B12 in B-Cell Depletion
Best Practice Articles
- Optimizing Experimental Design in In Vivo Research: A Comprehensive Review
- Enhancing Data Management and Analysis in In Vivo Research: Best Practices and Emerging Strategies
- Key Considerations for Selecting In Vivo Antibodies for Research
- Essential Factors to Consider When Evaluating In Vivo Antibody Suppliers
- Recombinant vs. Hybridoma Antibody Production: Key Differences and Considerations for In Vivo Antibody Selection
- Why ichorbio's In Vivo Production Methods Ensure Superior Quality
- A Beginners Guide on How to Inject Mice
- Optimizing Animal Husbandry in In Vivo Research: Best Practices and Strategies for Ensuring Animal Welfare and Study Validity
- Navigating the Ethical Landscape of In Vivo Research: Balancing Scientific Advancement and Animal Welfare
- Advancing Translational Research through Optimized Animal Models, Predictive Strategies, and Emerging Technologies
Citation Review Articles
- Interferon-Stimulated Neutrophils Predict Immunotherapy Response and Enhance Anti-Tumor Immunity
- Interleukin-9 Expressing Oncolytic Vaccinia Virus Transforms Tumor Microenvironment and Elicits Potent Antitumor Effects in Combination with CTLA-4 Blockade
- KVA12123: A Promising New Anti-VISTA Antibody for Cancer Immunotherapy
- Uncovering Immune Mechanisms and Predictors of Response to Anti-PD-1 Therapy in Liver Cancer
- Novel HDAC6/HSP90 Dual Inhibitors: A Promising Strategy to Enhance Cancer Immunotherapy
- Targeting PSGL-1 on Tumor-Associated Macrophages: A Promising Approach to Enhance Cancer Immunotherapy
- Targeting Extracellular NAMPT: A Promising Immunotherapy Strategy for Triple Negative Breast Cancer
- Boosting Immunotherapy with One-Carbon Donor Supplementation in Preclinical Cancer Models
- Monitoring Immunotherapy Response through Exosomal PD-L1 Profiling
- Citation Review: The Path to Understanding Type 1 Diabetes: Uncovering the Role of TYK2
- A Dynamic Duo: How Akkermansia muciniphila and Parabacteroides distasonis Protect Against Inflammatory Bowel Disease
- Engineered Immune Evasion: A Game-Changer for Cell Therapy
- Unveiling the Role of SIX4 in Regulating STING Expression and Anti-PD-1 Efficacy in Colon Cancer
- A New Immunotherapy Approach for Residual Liver Cancer after Incomplete Radiofrequency Ablation
- Understanding How PGE2 Causes Dendritic Cell Dysfunction in Cancer and Its Possible Treatments
- Breakthrough in Cancer Immunotherapy: Multiantigen T-Cell Hybridizers Show Promise in Treating Hematological Malignancies
- Uncovering Exhausted T Cell Phenotypes in Autoimmune Diseases: The Crucial Role of HLA Blocking Antibodies
- Persistent Microglial Activation: A Double-Edged Sword in Latent Cytomegalovirus Infection
- Riluzole Enhances Anti-PD-1 Efficacy in Colorectal Cancer by Activating cGAS/STING Signaling
- Targeting IRE1α Reshapes the Tumor Microenvironment and Enhances Immunotherapy in Prostate Cancer
- Dual Role of cGAS/STING Signaling in Colorectal Cancer Chemotherapy: Friend or Foe?
- eNAMPT Drives Abnormal Blood Vessel Formation in Triple-Negative Breast Cancer Through Direct Effects on Pericytes
- Breakthrough in De Novo Antibody Design Achieves Therapeutic-Grade Properties
- Does Dietary Fiber Really Boost Immunotherapy? A Closer Look at Inconsistent Outcomes in Murine Tumor Models
- Multi-Antigen T-Cell Hybridizers (MATCH): A New Frontier in Treating B-Cell Malignancies
- Rapid In Vivo Screening of Monoclonal Antibody Cocktails: A Game Changer in Therapeutic Development
- Unveiling the Journey of ECP-Treated Splenocytes: A Novel Protocol for Tracking Immunomodulation in Tumor and Colitis Models
- The Sound of Healing? Unpacking Boiling Histotripsy in Pancreatic Cancer Immunotherapy
- New Frontiers in Cancer Treatment: Unveiling the Potential of 3p-C-DEPA Chelators for Actinium-225 Targeted Alpha Therapy
- Revolutionizing Breast Cancer Treatment: Boosting Proteasome Inhibitor Efficacy Through CD8+ T Cell Immunity
- Oncolytic Virus Expressing Non-Secreted DR-18 Cytokine Induces Potent, Systemic Antitumor Immunity
- Humoral Immunity's Unexpected Role in Checkpoint Immunotherapy
- Harnessing Innate Immunity: F9H4, A Substrate-Specific Strategy to Unlock Fc-Enabled Therapeutics
- Omega-3 PUFAs Synergize with Anti-PD-1 Therapy to Counter Cholesterol-Driven NSCLC Immune Evasion
- Targeting Immune Dysfunction: A Synergistic Approach Using Anti-PD-1 Blockade and Micronutrient Supplementation in BVDV Infection
- Cytokine-Controlled Vulnerability: How TNF-α and IFN-γ Shape the Therapeutic Window for CD70-Targeted Immunotherapy in AML
- Decoding the Mineralized Microenvironment: Autonomous Paracrine Signaling and High-Fidelity Drug Response in a Nanoscale Bone-on-a-Chip
- The Phosphatase Factor: PPP2R2A Insufficiency Sensitizes NSCLC to PD-L1 Blockade via cGAS-STING Activation
- The Goldilocks Solution: Uncoupling CD137 Agonism from Hepatotoxicity via Nanoparticle-Mediated Ligand Multimerization
- The Metabokine Checkpoint: Targeting ANGPTL3 to Overcome Anti-PD-1 Resistance in Gastric Cancer
- Synergizing Thermal Ablation and CD40 Agonism: A New Paradigm for Immunologically "Cold" Breast Tumors
- Precision Glycomics: Leveraging Isotope Labeling for Enhanced Biosimilarity Assessment
- Engineering the Next Generation of NK Cell Therapeutics: Dual-Action Fc-Optimization of Anti-MICA/B Antibodies
- Targeting the IL-11 receptor in thyroid eye disease: from patient-derived fibroblasts to a phase 2 clinical breakthrough
Immune Checkpoint Articles
- Comparing Murine PD-1 and PD-L1 Monoclonal Antibodies for Cancer Immunotherapy Research
- Exploring the Most Commonly Used PD-1 Antibody Clones for In Vivo Research
- Maximizing the Potential of RMP1-14 in Immuno-Oncology and Preclinical Research
- Advancing Translational Research with RMP1-14: From PD-1 Pathway Insights to Clinical Applications
- Comparing RMP1-14 to Other Anti-PD-1 Clones: Advantages and Considerations for In Vivo Studies
- The Ultimate Guide to Using RMP1-14 for In Vivo PD-1 Blockade Studies
- Exploring the Origins and Evolution of Anti-PD-1 Clone RMP1-14: From Hybridoma to In Vivo Applications
- Understanding PD-1 Blockade In Infectious Diseases
Technique Articles
- Targeting Proteins for Immune Cell Depletion in Vivo
- Standard Protocol for Immune Cell Depletion in Vivo
- In Vivo Immune Checkpoint Blockade Assay Protocol
- Western Blot Standard Protocol
- A Beginners Guide on How to Inject Mice
- How to Deplete NK Cells in vivo
- How to deplete CD8+ T Cells in vivo
- How to deplete Neutrophils in vivo
- How to Deplete CD4+ T Cells in vivo
- Dendritic Cell Depletion In Vivo
